Regional particle size dependent deposition of inhaled aerosols in rats and mice
Authors:
- 7 December 2011
- journal article
- research article
- Published by Taylor & Francis in Inhalation Toxicology
- Vol. 24 (1) , 27-35
Abstract
Context: The current data analysis tools in nuclear medicine have not been used to evaluate intra organ regional deposition patterns of pharmaceutical aerosols in preclinical species. Objective: This study evaluates aerosol deposition patterns as a function of particle size in rats and mice using novel image analysis techniques. Materials and Method: Mice and rats were exposed to radiolabeled polydisperse aerosols at 0.5, 1.0, 3.0, and 5.0 µm MMAD followed by SPECT/CT imaging for deposition analysis. Images were quantified for both macro deposition patterns and regional deposition analysis using the LRRI-developed Onion Model. Results: The deposition fraction in both rats and mice was shown to increase as the particle size decreased, with greater lung deposition in rats at all particle sizes. The Onion Model indicated that the smaller particle sizes resulted in increased peripheral deposition. Discussion: These data contrast the commonly used 10% deposition fraction for all aerosols between 1.0 and 5.0 µm and indicate that lung deposition fraction in this range does change with particle size. When compared to historical data, the 1.0, 3.0, and 5.0 µm particles result in similar lung deposition fractions; however, the 0.5 µm lung deposition fraction is markedly different. This is probably caused by the current aerosols that were polydisperse to reflect current pharmaceutical aerosols, while the historical data were generated with monodisperse aerosols. Conclusion: The deposition patterns of aerosols between 0.5 and 5.0 µm showed an increase in both overall and peripheral deposition as the particle size decreased. The Onion Model allows a more complex analysis of regional deposition in preclinical models.Keywords
This publication has 20 references indexed in Scilit:
- Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary ReportJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD PatientsJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- RMV data analysis and conclusions by AIT Working PartyInhalation Toxicology, 2009
- Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with PharmaceuticalsInhalation Toxicology, 2008
- Comparison of SPECT Aerosol Deposition Data with a Human Respiratory Tract ModelJournal of Aerosol Medicine, 2006
- Comparison of SPECT Aerosol Deposition Data with Twenty-Four-Hour Clearance MeasurementsJournal of Aerosol Medicine, 2006
- The Effect of Lung Structure on Mucociliary Clearance and Particle Retention in Human and Rat LungsToxicological Sciences, 2003
- Respiratory Deposition and Inhalability of Monodisperse Aerosols in Long-Evans RatsToxicological Sciences, 2003
- Allometric respiration/body mass data for animals to be used for estimates of inhalation toxicity to young adult humansJournal of Applied Toxicology, 2000
- In Vitro Measurements of Delivery of Medications from MDIs and Spacer DevicesJournal of Aerosol Medicine, 1996